These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Current trends in the treatment of diabetes mellitus]. Jacobelli A Clin Ter; 1984 Aug; 110(3):277-81. PubMed ID: 6237866 [No Abstract] [Full Text] [Related]
27. Immunobiological studies in two cases of insulin-resistant diabetes. de Assis LM; Nicolau W; Salomon JB; de Cintra AB; Pieroni RR AMB Rev Assoc Med Bras; 1970 Jan; 16(1):5-18. PubMed ID: 5311115 [No Abstract] [Full Text] [Related]
28. [Significance of the preparative insulin chemistry for clinical diabetology]. Petrides P Dtsch Med Wochenschr; 1973 Nov; 98(47):2256-8. PubMed ID: 4271376 [No Abstract] [Full Text] [Related]
29. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)]. García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310 [No Abstract] [Full Text] [Related]
30. Autoantibodies to the insulin receptor: clinical and molecular aspects. Kahn CR Fed Proc; 1979 Nov; 38(12):2607-9. PubMed ID: 499577 [No Abstract] [Full Text] [Related]
31. [Antibodies to insulin--obvious and possible effects]. Livneh A Harefuah; 1986 May; 110(9):458-62. PubMed ID: 3530917 [No Abstract] [Full Text] [Related]
32. Insulin antibodies in diabetics receiving a single type of insulin. Mincu I; Cheţa D Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628 [TBL] [Abstract][Full Text] [Related]
34. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Andreani D; Iavicoli M; Colletti A; Menzinger G Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824 [No Abstract] [Full Text] [Related]
35. [Insulin immunogenicity and its various clinical aspects]. Rogala H Pol Tyg Lek; 1983 Jan; 38(4):127-30. PubMed ID: 6344050 [No Abstract] [Full Text] [Related]
37. [Insulin-binding antibodies and insulin resistance (author's transl)]. Waldhäusl W Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340 [No Abstract] [Full Text] [Related]
38. [Immunologic tolerance against insulin. A therapeutic goal to prevent immunological complications in the diabetic patient using insulin]. Jansen FK Med Welt; 1972 Nov; 23(48):1818-9. PubMed ID: 4654716 [No Abstract] [Full Text] [Related]
39. [The effect of antibodies on the activity and kinetics of administered insulin]. Páv J; Srámková J Cas Lek Cesk; 1982 Oct; 121(41):1258-61. PubMed ID: 6756634 [No Abstract] [Full Text] [Related]